Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BREIZH-Cohorte
NCT04297085Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- May 2020
- Primary completion
- Apr 2050
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Centre Hospitalier Universitaire de Brest. Primary endpoint: Recurrence of thromboembolic venous disease at 20 years. Started May 2020; status: recruiting.
Beyond the preview
Go deeper on NCT04297085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04297085.